Display options
Share it on

Korean J Anesthesiol. 2015 Feb;68(1):50-61. doi: 10.4097/kjae.2015.68.1.50. Epub 2015 Jan 28.

The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade.

Korean journal of anesthesiology

Won Ji Rhee, Seung Yoon Lee, Ji Hyeon Lee, So Ron Choi, Seung-Cheol Lee, Jong Hwan Lee, Soo-Il Lee

Affiliations

  1. Department of Anesthesiology and Pain Medicine, Dong-eui Medical Center, Busan, Korea.
  2. Department of Anesthesiology and Pain Medicine, Dong-A University College of Medicine, Busan, Korea.

PMID: 25664156 PMCID: PMC4318866 DOI: 10.4097/kjae.2015.68.1.50

Abstract

BACKGROUND: Magnesium, ropivacaine, gentamicin, and rocuronium block neuromuscular (NM) transmission by different mechanisms. Therefore, concurrent administration of these agents may induce prolonged muscle paralysis via synergistic interaction. This study investigated the efficacy and safety of NM block caused by the administration of high concentrations of magnesium in combination with ropivacaine, gentamicin, and rocuronium.

METHODS: Eighty-three left phrenic nerve-hemidiaphragms from male SD rats (150-250 g) were hung in Krebs solution. Three consecutive single twitch tension (ST, 0.1 Hz) and one tetanic tension (TT, 50 Hz for 1.9 s) were obtained before drug application and at each new drug concentration. The concentration of MgCl2 and MgSO4 in Krebs solution was increased until an 80 to 90% reduction in ST was reached. To test the effects of combinations of NM agents, a Krebs solution was premixed with MgCl2 alone, MgCl2 and ropivacaine, or MgCl2, ropivacaine, and gentamicin. The concentration of ropivacaine, gentamicin, or rocuronium was then progressively increased until an 80 to 90% reduction in ST was reached. The effective concentrations were estimated with a probit model.

RESULTS: The potency of MgCl2 was greater than that of MgSO4, and pretreatment with MgCl2 increased the potency of gentamicin and rocuronium. Unexpectedly, MgCl2 did not potentiate ropivacaine, and the potency of gentamicin and rocuronium failed to show an increase when premixed with 0.5 µM ropivacaine.

CONCLUSIONS: The concomitant administration of high concentrations of magnesium and ropivacaine together with clinically relevant concentrations of gentamicin or rocuronium potentiated NM blockade but not with clinically relevant concentrations of ropivacaine.

Keywords: Gentamicins; Magnesium; Neuromuscular blockade; Rocuronium; Ropivacaine

References

  1. Stroke. 1989 Sep;20(9):1273-5 - PubMed
  2. Acta Anaesthesiol Scand. 2010 Mar;54(3):299-306 - PubMed
  3. Br J Anaesth. 1997 May;78(5):507-14 - PubMed
  4. Magnes Res. 2005 Sep;18(3):187-92 - PubMed
  5. Korean J Anesthesiol. 2012 May;62(5):468-73 - PubMed
  6. Br J Anaesth. 1997 Jul;79(1):122-4 - PubMed
  7. Korean J Anesthesiol. 2013 Apr;64(4):346-52 - PubMed
  8. Pharmacol Toxicol. 1999 Dec;85(6):282-7 - PubMed
  9. J Pharmacol Exp Ther. 1981 May;217(2):369-78 - PubMed
  10. Anesth Analg. 1988 Nov;67(11):1047-52 - PubMed
  11. Br J Anaesth. 1996 Feb;76(2):278-83 - PubMed
  12. Clin Pharmacol Ther. 1978 Mar;23(3):356-60 - PubMed
  13. Anesth Analg. 1978 Sep-Oct;57(5):580-7 - PubMed
  14. J Physiol. 1965 Jun;178(3):505-29 - PubMed
  15. Clin Pharmacokinet. 2000 Apr;38(4):305-14 - PubMed
  16. J Physiol. 1978 Apr;277:153-76 - PubMed
  17. J Gen Physiol. 1992 Apr;99(4):491-504 - PubMed
  18. Korean J Anesthesiol. 2013 Feb;64(2):143-51 - PubMed
  19. Anesth Analg. 1988 Nov;67(11):1053-8 - PubMed
  20. Anesthesiology. 1990 Apr;72 (4):711-34 - PubMed
  21. Clin Exp Pharmacol Physiol. 1976 Nov-Dec;3(6):545-55 - PubMed
  22. Can J Anaesth. 2003 Feb;50(2):172-8 - PubMed
  23. Anesthesiology. 2011 Apr;114(4):971-93 - PubMed
  24. Anesth Analg. 1992 Jan;74(1):129-36 - PubMed
  25. Eur J Pharmacol. 2010 Mar 25;630(1-3):29-33 - PubMed
  26. Crit Care Med. 1983 Jan;11(1):55-6 - PubMed
  27. Mini Rev Med Chem. 2002 Aug;2(4):385-410 - PubMed
  28. J Physiol. 1954 May 28;124(2):370-84 - PubMed

Publication Types